feed,title,long_url,short_url
SeekingAlpha,Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout,https://seekingalpha.com/article/4702081,
SeekingAlpha,Cartesian: Further Value To Be Unlocked After Positive MG Treatment Data,https://seekingalpha.com/article/4702079,
SeekingAlpha,Palantir Stock Is Not Worth The Risk Anymore (Downgrade),https://seekingalpha.com/article/4702078,
SeekingAlpha,U.S. Silica Has Upside To Sum Of The Parts Valuation In A Potential Split,https://seekingalpha.com/article/4702077,
